Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. (RKDA) scores 35 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $-17.64, representing a 91% margin of safety.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full RKDA analysis on boothcheck